Center for Health Market Innovations (CHMI)

Programs

Masunurin Value Packs (MVP)

last updated May 2, 2012

Overview

Implementing organization: 
Pharex
Legal Status: 
Private (for-profit)
Stage: 
Existing/expansion stage
Income Level of Target Population: 
Bottom 20%, 20-60% (lower to lower-middle)
Summary: 

“Masunurin” means obedient or compliant in Filipino. The program is intended to increase adherence to drug regimens by countering poor Filipinos’ tendency to purchase drugs one at a time (“tingi”) and cease taking the medicines once they feel better.

Key program components: 

Pharex’s Masunurin Value Packs (MVP) provide essential medicines in pre-packaged form and offer a customer discount to enhance drug compliance on the basis of doctor’s prescription.

MVPs offer popular antibiotics in resealable foil packaging. Each package includes a minimum full dose. Compliance packs include:

  • amoxicillin 500 mg., 15 capsules, for Php75 (approximately USD 1.75), a 31 percent savings compared to individual capsule purchases);
  • cephalexin 500 mg, 15 capsules, Php 150 (USD 3.55), a 47 percent savings;
  • ciprofloxacin 500 mg., 10 tablets, Php150 (USD 3.55), a 25 percent savings; and
  • cloxacillin 500 mg, 20 capsules, Php 170 (approximately USD 4), a 52 percent savings
Hide this

Need help?

Using the CHMI Programs Database

  • Browse: Browse the database by applying one or more filters to narrow your search by characteristics. Click the "x" to remove any of the filters you've selected. Click "reset search" to remove all filters and start over.
  • Search: Search the database for a specific program by typing a name or keyword into the search box.
  • Add: If the program you're looking for is not in the CHMI database, submit the program to the CHMI pipeline by clicking here to add a program profile.
  • Update: If you notice incorrect or outdated information, or would like to help complete a profile for a CHMI pipeline program, request a change by clicking here, or at the top of the program profile.

Have a question? Check the FAQs first. Don’t see your question? Contact us.